Condition

Stage IIA Lung Cancer AJCC v8

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 29 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials29

Recruiting6

Common interventions25

Lead sponsors shown13

Clinical trials

29 shown

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung CancerNCT05292521 · 2023-12-21

Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung CancerNCT05136846 · 2021-12-06

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung TrialNCT04789681 · 2021-07-20

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296 · 2021-02-21

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung CancerNCT04067830 · 2019-03-20

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversNCT03948100 · 2018-12-20

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and LungNCT05412875 · 2024-01-01

Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung CancerNCT05340309 · 2022-12-07

ACTIVE_NOT_RECRUITING

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or RecurrenceNCT04298606 · 2021-11-22

Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung CancerNCT04705025 · 2021-04-08

Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME StudyNCT05022394 · 2021-02-18

Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung CancerNCT04751747 · 2021-02-11

ACTIVE_NOT_RECRUITING

NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung CancerNCT04505267 · 2021-02-10

ACTIVE_NOT_RECRUITING

Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung CancerNCT04348292 · 2021-01-22

Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung CancerNCT04560686 · 2020-08-05

Family Caregivers in Underserved Populations Providing Complex Cancer CareNCT05213078 · 2020-07-15

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerNCT04428905 · 2020-07-11

ACTIVE_NOT_RECRUITING

Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung CancerNCT04061590 · 2020-05-29

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac ChangesNCT04183218 · 2019-09-23

Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung CancerNCT04013542 · 2019-09-13

ACTIVE_NOT_RECRUITING

Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME StudyNCT04430725 · 2019-08-07

ACTIVE_NOT_RECRUITING

Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung CancerNCT03995667 · 2019-06-11

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With CancerNCT03939481 · 2019-05-14

ACTIVE_NOT_RECRUITING

Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversNCT03902535 · 2019-03-08

Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsNCT03867916 · 2018-12-13

Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing TreatmentNCT03731585 · 2018-11-15

ACTIVE_NOT_RECRUITING

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung StudyNCT03634241 · 2018-11-13

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung CancerNCT03110978 · 2017-06-26

ACTIVE_NOT_RECRUITING

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26

ACTIVE_NOT_RECRUITING

Common interventions

Leading sponsors

M.D. Anderson Cancer Center 11 City of Hope Medical Center 3 Roswell Park Cancer Institute 3 Ohio State University Comprehensive Cancer Center 2 University of California, San Francisco 2 Emory University 1 Jonsson Comprehensive Cancer Center 1 Mayo Clinic 1 National Cancer Institute (NCI) 1 OHSU Knight Cancer Institute 1 Rutgers, The State University of New Jersey 1 SWOG Cancer Research Network 1 University of Southern California 1

Trial status mix

ACTIVE_NOT_RECRUITING10

COMPLETED6

RECRUITING6

TERMINATED4

WITHDRAWN3

Phase mix

NA9

PHASE29

PHASE16

EARLY_PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.